1. A randomized, double-blind, phase III study comparing two doses of erlotinib for second-line treatment of current smokers with advanced non-small-cell lung cancer (CurrentS). (September 2016) Authors: Smit, Egbert F.; Wu, Yi-Long; Gervais, Radj; Zhou, Caicun; Felip, Enriqueta; Feng, Jifeng; Guclu, Salih Zeki; Hoiczyk, Mathias; Dorokhova, Elena; Freudensprung, Ulrich; Grange, Susan; Perez-Moreno, Pablo Diego; Mitchell, Lada; Reck, Martin Journal: Lung cancer Issue: Volume 99(2016) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. Issue 10026 (2nd April 2016) Authors: Zalcman, Gérard; Mazieres, Julien; Margery, Jacques; Greillier, Laurent; Audigier-Valette, Clarisse; Moro-Sibilot, Denis; Molinier, Olivier; Corre, Romain; Monnet, Isabelle; Gounant, Valérie; Rivière, Frédéric; Janicot, Henri; Gervais, Radj; Locher, Chrystèle; Milleron, Bernard; Tran, Quan; Lebit... Journal: Lancet Issue: Volume 387:Issue 10026(2016) Page Start: 1405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial. Issue 9 (September 2020) Authors: Baize, Nathalie; Monnet, Isabelle; Greillier, Laurent; Geier, Margaux; Lena, Hervé; Janicot, Henri; Vergnenegre, Alain; Crequit, Jacky; Lamy, Regine; Auliac, Jean-Bernard; Letreut, Jacques; Le Caer, Hervé; Gervais, Radj; Dansin, Eric; Madroszyk, Anne; Renault, Patrick-Aldo; Le Garff, Gwenaëlle; F... Journal: Lancet oncology Issue: Volume 21:Issue 9(2020) Page Start: 1224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Case Report about Fatal or Near-Fatal Hypersensitivity Reactions to Cetuximab: Anticetuximab IgE as a Valuable Screening Test. (January 2014) Authors: Dupont, Benoît; Mariotte, Delphine; Moldovan, Cristian; Grellard, Jean-Michel; Vergnaud, Marie-Claude; Laroche, Dominique; Gervais, Radj Journal: Clinical medicine insights. Oncology Issue: Volume 8(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohort. (May 2020) Authors: Sanchis-Borja, Mateo; Ricordel, Charles; Chiappa, Anne Marie; Hureaux, José; Odier, Luc; Jeannin, Gaelle; Descourt, Renaud; Gervais, Radj; Monnet, Isabelle; Auliac, Jean-Bernard; Chouaïd, Christos Journal: Lung cancer Issue: Volume 143(2020) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Identification of I1171N resistance mutation in ALK-positive non-small-cell lung cancer tumor sample and circulating tumor DNA. (September 2016) Authors: Johnson, Alison C.; Dô, Pascal; Richard, Nicolas; Dubos, Catherine; Michels, Jean Jacques; Bonneau, Jessica; Gervais, Radj Journal: Lung cancer Issue: Volume 99(2016) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC – IFCT 02-01. (January 2016) Authors: Fournel, Pierre; Vergnenégre, Alain; Robinet, Gilles; Léna, Hervé; Gervais, Radj; Le Caer, Hervé; Souquet, Pierre-Jean; Chavaillon, Jean-Michel; Bozonnat, Marie-Cécile; Daurès, Jean-Pierre; Chouaid, Christos; Martel-Lafay, Isabelle Journal: European journal of cancer Issue: Volume 52(2016) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors. Issue 1 (26th January 2020) Authors: Dolladille, Charles; Ederhy, Stephane; Allouche, Stéphane; Dupas, Querntin; Gervais, Radj; Madelaine, Jeannick; Sassier, Marion; Plane, Anne-Flore; Comoz, Francois; Cohen, Ariel Aron; Thuny, Franck Roland; Cautela, Jennifer; Alexandre, Joachim Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review. Issue 11 (2nd November 2018) Authors: Lesueur, Paul; Martel-Laffay, Isabelle; Escande, Alexandre; Kissel, Manon; Locher, Chrystel; Gervais, Radj; Schott, Roland; Vergnenegre, Alain; Chouaid, Christos Journal: Expert review of anticancer therapy Issue: Volume 18:Issue 11(2018) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use of immunotherapy in these patients: the GFPC 03-2017 "EPNEC" study. (July 2020) Authors: Arpin, Dominique; Charpentier, Marie-Christine; Bernardi, Marie; Monnet, Isabelle; Boni, Aurelie; Watkin, Emmanuel; Goubin-Versini, Isabelle; Lamy, Régine; Gérinière, Laurence; Geier, Margaux; Forest, Fabien; Gervais, Radj; Madrosyk, Anne; Guisier, Florian; Serrand, Cécile; Locher, Chrystèle; Dec... Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗